GLS and cancer: Glutaminase inhibition then suppresses cancer cell growth, elevates intracellular ROS, and concurrently upregulates uridine phosphorylase 1 (UPP1), which promotes 5-FU conversion to its active form and thereby enhances 5-FU efficacy (171).